Genomic Characterization of Carbapenem-Resistant Acinetobacter baumannii (OXA-23) and Klebsiella pneumoniae (KPC-2) Causing Hospital-Acquired Infections in Dogs
- PMID: 40558175
- PMCID: PMC12189288
- DOI: 10.3390/antibiotics14060584
Genomic Characterization of Carbapenem-Resistant Acinetobacter baumannii (OXA-23) and Klebsiella pneumoniae (KPC-2) Causing Hospital-Acquired Infections in Dogs
Abstract
Background/Objectives: Antimicrobial resistance is a major global health threat. Among the most problematic pathogens are carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae, which are significant causes of mortality in humans, particularly in the context of nosocomial infections. In companion animals, these bacteria have been reported mainly as colonizers of healthy animals or, less frequently, in community-acquired infections. However, no confirmed cases of healthcare-associated infections caused by these species have been documented in this population. This study reports the first confirmed fatal cases of infection with carbapenem-resistant A. baumannii and KPC-producing K. pneumoniae in dogs. Methods: Three hospitalized dogs developed infections associated with distinct anatomical devices, including a venous catheter, an endotracheal tube, and a Penrose drain. Bacterial isolation followed by antimicrobial susceptibility testing identified carbapenem-resistant A. baumannii and K. pneumoniae. The isolates were subsequently subjected to additional antimicrobial resistance tests and whole-genome sequencing (WGS). Results: WGS confirmed the presence of the OXA-23 carbapenemase gene in both A. baumannii isolates and the KPC-2 carbapenemase gene was detected in the K. pneumoniae strain. All three strains exhibited resistance to multiple antimicrobial classes, including β-lactams (amoxicillin-clavulanic acid, ampicillin, cephalotin, piperacillin-tazobactam, cefoxitin, ceftiofur, cefotaxime, ertapenem, imipenem and meropenem), aminoglycosides (gentamicin, neomycin), tetracyclines (doxycycline, tetracycline and oxytetracycline), fluoroquinolones (ciprofloxacin, enrofloxacin), and folate pathway antagonists (trimethoprim-sulfamethoxazole). Multilocus sequence typing identified two high-risk clones: K. pneumoniae ST340 (CC258) and A. baumannii ST15 (CC15). Single nucleotide polymorphism analysis confirmed a high degree of genetic similarity between these isolates and strains previously associated with human infections in Brazil. Conclusions: These findings provide the first evidence of fatal, healthcare-associated infections caused by these multidrug-resistant pathogens in dogs and underscore the need to strengthen surveillance and infection control practices in veterinary hospitals. Furthermore, the results raise concerns about the potential of companion animals to act as reservoirs for multidrug-resistant organisms of public health relevance.
Keywords: Acinetobacter baumannii; ESKAPE; KPC-2; Klebsiella pneumoniae; OXA-23; carbapenem-resistance; companion animals; healthcare-associated infection.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
Genomic surveillance for multidrug-resistant or hypervirulent Klebsiella pneumoniae among United States bloodstream isolates.BMC Infect Dis. 2022 Jul 7;22(1):603. doi: 10.1186/s12879-022-07558-1. BMC Infect Dis. 2022. PMID: 35799130 Free PMC article.
-
Whole-Genome Sequencing and Bioinformatics Analysis of ESBL- producing Klebsiella pneumoniae in a Ghanaian teaching hospital.BMC Microbiol. 2025 Jul 2;25(1):401. doi: 10.1186/s12866-025-04101-5. BMC Microbiol. 2025. PMID: 40604438 Free PMC article.
-
Nationwide surveillance of carbapenem-resistant Gram-negative pathogens in the Lebanese environment.Appl Environ Microbiol. 2025 Jul 23;91(7):e0193224. doi: 10.1128/aem.01932-24. Epub 2025 Jun 10. Appl Environ Microbiol. 2025. PMID: 40492734 Free PMC article.
-
A systematic review and meta-analysis for risk factor profiles in patients with resistant Acinetobacter baumannii infection relative to control patients.Int J Risk Saf Med. 2023;34(4):337-355. doi: 10.3233/JRS-220037. Int J Risk Saf Med. 2023. PMID: 37154184
-
Fecal microbiota transplantation for Carbapenem-Resistant Enterobacteriaceae: A systematic review.J Infect. 2022 Jun;84(6):749-759. doi: 10.1016/j.jinf.2022.04.028. Epub 2022 Apr 21. J Infect. 2022. PMID: 35461908
References
-
- Čiginskienė A., Dambrauskienė A., Rello J., Adukauskienė D. Ventilator-Associated Pneumonia Due to Drug-Resistant Acinetobacter baumannii: Risk Factors and Mortality Relation with Resistance Profiles, and Independent Predictors of In-Hospital Mortality. Medicina. 2019;55:49. doi: 10.3390/medicina55020049. - DOI - PMC - PubMed
-
- Pachanon R., Khine N.O., Phumthanakorn N., Wongsurawat T., Niyomtham W., Chatsuwan T., Hampson D.J., Prapasarakul N. Genomic Characterization of Carbapenem and Colistin-Resistant Klebsiella pneumoniae Isolates from Humans and Dogs. Front. Vet. Sci. 2024;11:1386496. doi: 10.3389/fvets.2024.1386496. - DOI - PMC - PubMed
-
- Magiorakos A.-P., Srinivasan A., Carey R.B., Carmeli Y., Falagas M.E., Giske C.G., Harbarth S., Hindler J.F., Kahlmeter G., Olsson-Liljequist B., et al. Multidrug-Resistant, Extensively Drug-Resistant and Pandrug-Resistant Bacteria: An International Expert Proposal for Interim Standard Definitions for Acquired Resistance. Clin. Microbiol. Infect. 2012;18:268–281. doi: 10.1111/j.1469-0691.2011.03570.x. - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources